The collected data seem to indicate that these modifications in the structure of tryptophan-betaxanthin could be relevant in the binding affinities between betaxanthin and the different targets involved in the cancer disease and in the interactions with the receptors or proteins, such as the Sirt1 protein, FTO protein, and PPARs [22,23,36]. Here, FTO is linked to cancer.